impact of durvalumab as consolidation therapy in nsclc
Published 6 years ago • 228 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
5:28
durvalumab consolidation in nsclc: the pacific trial
-
1:28
durvalumab as a consolidation therapy for locally advanced nsclc
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
4:15
safety profile of durvalumab in locally advanced nsclc
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
3:07
the use of durvalumab in locally advanced nsclc
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
6:22
refining which patients benefit from consolidation durvalumab for stage iii unresectable nsclc
-
2:10
dr. langer on the benefit of durvalumab in stage iii nsclc
-
1:37
results for durvalumab in the second-line treatment of nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
6:23
case 1: consolidation therapy in locally advanced nsclc
-
1:45
enhancing benefit with durvalumab in nsclc after the pacific trial
-
6:06
stage iii nsclc: when to start durvalumab
-
3:25
impact of radiation dose to immune cells in unresectable or stage iii nsclc in the durvalumab era
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
1:29
how can durvalumab be used in nsclc?
-
4:13
implications of durvalumab following pacific update
-
5:14
tips for managing nsclc patients on durvalumab therapy